Monte Rosa Therapeutics (GLUE) EBT Margin (2024 - 2026)
Monte Rosa Therapeutics (GLUE) recorded quarterly EBT Margin of 1033.74% in Q1 2026, up 2.32% quarter-over-quarter from 1058.25% in Q4 2025, and down 108992.0% on a YoY basis from N/an in Q1 2025.
Monte Rosa Therapeutics (GLUE) EBT Margin (2024 - 2026) Analysis & Trends
Monte Rosa Therapeutics' EBT Margin history runs 3 years deep, the most recent figure standing at 1033.74% for Q1 2026.
- In Q1 2026, EBT Margin fell 108992.0% year-over-year to 1033.74%; the TTM figure through Mar 2026 stood at 2679.88% (down 268582.0% YoY), while the FY2025 annual figure was 18.66%, up 7408.0% from the prior year.
- EBT Margin was 1033.74% for Q1 2026 at Monte Rosa Therapeutics, up from 1058.25% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 56.17% in Q1 2025 to a low of 2996.71% in Q1 2024.
- Historically, EBT Margin has averaged 663.68% across 3 years, with a median of 258.12% in 2024.
- The sharpest annual moves came in 2025 and 2026: EBT Margin soared 305288 bps in 2025, then slumped 108992 bps in 2026.
- A 3-year view of EBT Margin shows it stood at 25.72% in 2024, then sank by 4214 bps to 1058.25% in 2025, then increased by 2 bps to 1033.74% in 2026.
- The last three EBT Margin figures came in at 1033.74% (Q1 2026), 1058.25% (Q4 2025), and 20.17% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Monte Rosa Therapeutics | 1.83 Bn | 1.15 Bn | - | -1,033.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,033.74% |
| Dec 31, 2025 | -1,058.25% |
| Sep 30, 2025 | -20.17% |
| Jun 30, 2025 | -47.84% |
| Mar 31, 2025 | 56.17% |
| Dec 31, 2024 | 25.72% |
| Sep 30, 2024 | -258.12% |
| Jun 30, 2024 | -640.21% |
| Mar 31, 2024 | -2,996.71% |